title: Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
authors.forename: Mohamed L
authors.initials: ML
authors.lastname: Sorror
authors.forename: Wendy
authors.initials: W
authors.lastname: Leisenring
authors.forename: H Joachim
authors.initials: HJ
authors.lastname: Deeg
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Martin
authors.forename: Rainer
authors.initials: R
authors.lastname: Storb
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D006650:Histocompatibility Testing; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use*; D011292:Premedication; D015995:Prevalence; D016019:Survival Analysis
chemical_list: D016572:Cyclosporine; D008727:Methotrexate